Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

5.497 -0.273 (-4.73%)
Streaming Delayed Price Updated: 10:24 AM EDT, Aug 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,977,265
Open 5.720
Bid (Size) 5.490 (91)
Ask (Size) 5.500 (227)
Prev. Close 5.770
Today's Range 5.450 - 5.735
52wk Range 3.790 - 12.36
Shares Outstanding 168,425,907
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Avant Technologies and Ainnova Tech Announce Enhanced Patient Recruitment Strategy Ahead of FDA Clinical Trial
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:RXRX),(NASDAQ:RLYB),(NASDAQ:BTAI),(NYSE:PFE) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term
These companies are in the right place at the right time with the right products. 
Via The Motley Fool
Topics Artificial Intelligence

Performance

YTD
-23.8%
-23.8%
1 Month
-5.9%
-5.9%
3 Month
+21.9%
+21.9%
6 Month
-48.3%
-48.3%
1 Year
-23.1%
-23.1%

More News

Read More
Why Recursion Pharmaceuticals Stock Tanked on Tuesday
Via The Motley Fool
Earnings Scheduled For August 5, 2025
Via Benzinga
Recursion Pharmaceuticals Earnings Preview
Via Benzinga
Recursion to Report Second Quarter 2025 Business Updates and Financial Results on August 5th
From Recursion Pharmaceuticals
Via GlobeNewswire
Recursion (RXRX) Q2 Revenue Jumps 33%
Via The Motley Fool
Topics Artificial Intelligence
Recursion Pharmaceuticals Reports Wider-Than-Expected Q2 Loss, Beats Revenue Estimates
Via Benzinga
Recursion Pharmaceuticals-A (NASDAQ:RXRX) Reports Mixed Q2 2025 Earnings: Revenue Beat but EPS Miss
Via Chartmill
Recursion Reports Second Quarter 2025 Financial Results and Provides Business Update
From Recursion Pharmaceuticals
Via GlobeNewswire
The Dawn of Hyper-Personalization: How Generative AI is Reshaping Our Digital World
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
2 Beaten-Down Stocks With Incredible Upside Potential
Via The Motley Fool
Why Recursion Pharmaceuticals Stock Got Mashed on Monday
Via The Motley Fool
The Median Retirement Savings for American Households Is $87,000. Here Are 3 Incredible Stocks to Buy Now and Hold for Decades.
Via The Motley Fool
Topics Artificial Intelligence Retirement
Palantir, Nvidia & Tempus AI Could Be Pharma ETF Darlings That Don't Make Pills
Via Benzinga
Topics Artificial Intelligence ETFs
How Palantir, Tempus, Nvidia-Backed Recursion Are Disrupting Big Pharma
Via Benzinga
3 AI Stocks Partnered With Nvidia With Massive Growth Opportunities
Via The Motley Fool
Topics Artificial Intelligence
Biocomputers: The Future of Computing is Alive
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
Recursion Pharmaceuticals Sees Sharp Gain on AI Biotech Optimism
Via MarketMinute
Topics Artificial Intelligence
Top 2 Health Care Stocks You May Want To Dump This Quarter
Via Benzinga
History of Recursion Pharmaceuticals, Inc.: AI‑Driven Drug Discovery Beginnings (NASDAQ:RXRX)
Via MarketMinute
Topics Artificial Intelligence
Is Recursion Pharmaceuticals Gaining or Losing Market Support?
Via Benzinga
Why Is Recursion Pharma Stock Surging On Monday?
Via Benzinga
Galaxy Digital, Blaize Holdings, Verizon And Other Big Stocks Moving Higher On Monday
Via Benzinga
Jensen Huang's Nvidia Owns 6 Stocks. Here's the Best of the Bunch.
Via The Motley Fool
Topics Artificial Intelligence Initial Public Offering Intellectual Property

Frequently Asked Questions

Is Recursion Pharmaceuticals, Inc. - Class A Common Stock publicly traded?
Yes, Recursion Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.
What exchange does Recursion Pharmaceuticals, Inc. - Class A Common Stock trade on?
Recursion Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock?
The ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock is RXRX on the Nasdaq Stock Market
What is the current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock?
The current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock is 5.497
When was Recursion Pharmaceuticals, Inc. - Class A Common Stock last traded?
The last trade of Recursion Pharmaceuticals, Inc. - Class A Common Stock was at 08/18/25 10:24 AM ET
What is the market capitalization of Recursion Pharmaceuticals, Inc. - Class A Common Stock?
The market capitalization of Recursion Pharmaceuticals, Inc. - Class A Common Stock is 925.80M
How many shares of Recursion Pharmaceuticals, Inc. - Class A Common Stock are outstanding?
Recursion Pharmaceuticals, Inc. - Class A Common Stock has 926M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.